Literature DB >> 30906163

Strategic Opportunities for Leveraging Low-cost, High-impact Technological Innovations to Promote Cardiovascular Health in India.

Dorairaj Prabhakaran1,2,3, Vamadevan S Ajay1,2, Nikhil Tandon4.   

Abstract

Accelerated epidemiological transition in India over the last 40 years has resulted in a dramatic increase in the burden of cardiovascular diseases and the related risk factors of diabetes and hypertension. This increase in disease burden has been accompanied by pervasive health disparities associated with low disease detection rates, inadequate awareness, poor use of evidence-based interventions, and low adherence rates among patients in rural regions in India and those with low socioeconomic status. Several research groups in India have developed innovative technologies and care-delivery models for screening, diagnosis, clinical management, remote-monitoring, self-management, and rehabilitation for a range of chronic conditions. These innovations can leverage advances in sensor technology, genomic tools, artificial intelligence, big-data analytics, and so on, for improving access to and delivering quality and affordable personalized medicine in primary care. In addition, several health technology start-ups are entering this booming market that is set to grow rapidly. Innovations outside biomedical space (eg, protection of traditional wisdom in diet, lifestyle, yoga) are equally important and are part of a comprehensive solution. Such low-cost, culturally tailored, robust innovations to promote health and reduce disparities require partnership among multi-sectors including academia, industry, civil society, and health systems operating in a conducive policy environment that fosters adequate public and private investments. In this article, we present the unique opportunity for India to use culturally tailored, low-cost, high-impact technological innovations and strategies to ameliorate the perennial challenges of social, policy, and environmental challenges including poverty, low educational attainment, culture, and other socioeconomic factors to promote cardiovascular health and advance health equity.

Entities:  

Keywords:  Cardiovascular Diseases; Diabetes; India; Innovations; Multi-disciplinary; Policy; Technology

Mesh:

Year:  2019        PMID: 30906163      PMCID: PMC6428188          DOI: 10.18865/ed.29.S1.145

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  20 in total

1.  Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial.

Authors:  Mohammed K Ali; Kavita Singh; Dimple Kondal; Raji Devarajan; Shivani A Patel; Roopa Shivashankar; Vamadevan S Ajay; A G Unnikrishnan; V Usha Menon; Premlata K Varthakavi; Vijay Viswanathan; Mala Dharmalingam; Ganapati Bantwal; Rakesh Kumar Sahay; Muhammad Qamar Masood; Rajesh Khadgawat; Ankush Desai; Bipin Sethi; Dorairaj Prabhakaran; K M Venkat Narayan; Nikhil Tandon
Journal:  Ann Intern Med       Date:  2016-07-12       Impact factor: 25.391

Review 2.  Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.

Authors:  Bernard J Gersh; Karen Sliwa; Bongani M Mayosi; Salim Yusuf
Journal:  Eur Heart J       Date:  2010-02-22       Impact factor: 29.983

3.  A Cluster-Randomized, Controlled Trial of a Simplified Multifaceted Management Program for Individuals at High Cardiovascular Risk (SimCard Trial) in Rural Tibet, China, and Haryana, India.

Authors:  Maoyi Tian; Vamadevan S Ajay; Danzeng Dunzhu; Safraj S Hameed; Xian Li; Zhong Liu; Cong Li; Hao Chen; KaWing Cho; Ruilai Li; Xingshan Zhao; Devraj Jindal; Ishita Rawal; Mohammed K Ali; Eric D Peterson; Jiachao Ji; Ritvik Amarchand; Anand Krishnan; Nikhil Tandon; Li-Qun Xu; Yangfeng Wu; Dorairaj Prabhakaran; Lijing L Yan
Journal:  Circulation       Date:  2015-07-17       Impact factor: 29.690

4.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

5.  Socioeconomic status and cardiovascular risk in urban South Asia: The CARRS Study.

Authors:  Mohammed K Ali; Binukumar Bhaskarapillai; Roopa Shivashankar; Deepa Mohan; Zafar A Fatmi; Rajendra Pradeepa; M Masood Kadir; Viswanathan Mohan; Nikhil Tandon; K M Venkat Narayan; Dorairaj Prabhakaran
Journal:  Eur J Prev Cardiol       Date:  2015-04-27       Impact factor: 7.804

6.  Glycemic control among individuals with self-reported diabetes in India--the ICMR-INDIAB Study.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Mohan Deepa; Rajendra Pradeepa; Shashank R Joshi; Anil Bhansali; Vinay K Dhandania; Prashant P Joshi; Sri Venkata Madhu; Paturi Vishnupriya Rao; Ramakrishnan Lakshmy; Ramamurthy Jayashri; Kaliaperumal Velmurugan; Elangovan Nirmal; Radhakrishnan Subashini; Venkataraman Vijayachandrika; Tanvir Kaur; Deepak Kumar Shukla; Ashok Kumar Das; Viswanathan Mohan
Journal:  Diabetes Technol Ther       Date:  2014-08-07       Impact factor: 6.118

7.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

8.  Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial.

Authors:  Ambady Ramachandran; Chamukuttan Snehalatha; Jagannathan Ram; Sundaram Selvam; Mary Simon; Arun Nanditha; Ananth Samith Shetty; Ian F Godsland; Nish Chaturvedi; Azeem Majeed; Nick Oliver; Christofer Toumazou; K George Alberti; Desmond G Johnston
Journal:  Lancet Diabetes Endocrinol       Date:  2013-09-11       Impact factor: 32.069

9.  Technology, innovation and health equity.

Authors:  Hildy Fong; Eva Harris
Journal:  Bull World Health Organ       Date:  2015-07-01       Impact factor: 9.408

10.  Task shifting of frontline community health workers for cardiovascular risk reduction: design and rationale of a cluster randomised controlled trial (DISHA study) in India.

Authors:  Panniyammakal Jeemon; Gitanjali Narayanan; Dimple Kondal; Kashvi Kahol; Ashok Bharadwaj; Anil Purty; Prakash Negi; Sulaiman Ladhani; Jyoti Sanghvi; Kuldeep Singh; Deksha Kapoor; Nidhi Sobti; Dorothy Lall; Sathyaprakash Manimunda; Supriya Dwivedi; Gurudyal Toteja; Dorairaj Prabhakaran
Journal:  BMC Public Health       Date:  2016-03-15       Impact factor: 3.295

View more
  1 in total

1.  Prevention and management of CVD in LMICs: why do ethnicity, culture, and context matter?

Authors:  Shuchi Anand; Christina Bradshaw; Dorairaj Prabhakaran
Journal:  BMC Med       Date:  2020-01-24       Impact factor: 8.775

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.